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Objective
to assess myocardial fibrosis in lamin A/C mutations
(LM) carriers using constrast-enhanced cardiac magnetic
resonance (CMR).
Background
LM carriers usually develop a dilated cardiomyopathy
(DCM) phenotype in association with atrio-ventricular
blocks and/or ventricular arrhythmias. However, sudden
cardiac death may be the first clinical manifestation.
Hence early detection of myocardial abnormalities
before overt left ventricular (LV) dysfunction is war-
ranted for a better risk stratification.
Methods
Seventeen paucisymptomatic LM carries (age 41±16
years, 9 male), 14 paucisymptomatic DCM patients (age
59±11 years, 8 male, NYHA I-II) with mild LV dysfunc-
tion (ejection-fraction 40%-55%) and 12 healthy controls
(age 46±10 years, 9 male) underwent complete clinical,
echocardiographic, biohumoral and contrast-enhanced
CMR assessment. Cine CMR was used to derive LV
volumes, mass and function, and post-contrast CMR to
detect late gadolinium enhancement (LGE) as an index of
gross fibrosis. Eight LM patients, all DCM patients and
all normal controls underwent pre- and post-contrast
myocardial T1 mapping with gadolinium partition coeffi-
cient calculation, as an index of interstitial fibrosis.
Results
LM carriers presented a similar LV end-diastolic volume
(85±17 ml/m2, p=NS) and slightly reduced ejection-frac-
tion (61±6% p<0.001) than controls (83±19 ml/m2,
67±6%), while in DCM patients LV end-diastolic volume
(102±17 ml/m2) and ejection-fraction (49±5%) were worse
than both controls and LM carriers (p<0.001). Moreover,
DCM patients presented worse diastolic dysfunction (9±3
vs 7±1, p<0.01), NT-proBNP plasma levels (438±416 vs
108±139 ng/l, p<0.01) and Doppler-estimated pulmonary
pressure (33±7 vs 30±5 mmHg, p<0.01) than LM carriers.
Six (43%) DCM patients presented DE, representing 9±3%
of LV mass; similarly, seven (42%) LM carriers had DE,
but with a larger extension (11±5% of LV mass, p<0.03).
In LM carries DE distribution was patchy (2 pts) or mid-
wall (5 pt), similarly to DCM patients (patchy in 1 pt, mid-
wall in 4 pts, subendocardial in 1 pt). GPC reached a
steady state 5 minutes after gadolinium injection. In DCM
patients GPC was slightly higher than controls (0.42±0.05
vs 0.38±0.06, p=0.04), while in LM carriers it was much
higher (0.45±0.07) than controls (p<0.01). Even excluding
hyperenhanced myocardium, in LM carriers GPC
remained higher than controls, while in DCM patients
only slightly higher than controls.
Conclusions
Myocardial fibrosis occurs early in LM carrier before LV
dilatation and dysfunction and may represent an early
phenotypic expression of cardiac involvement.
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